Help us: Donate
Follow us on:




March 03, 2021
BioAge, in a recent press release, has announced the start of its phase 2a clinical trial in elderly patients with unexplained anemia. BioAge is a California-based company founded in 2015 with a very direct focus on aging. It utilizes a systems biology approach and AI-based drug discovery platform to target important pathways which are found...
March 02, 2021
This is part one of a two-part article where we take a look at NAD+ biology, its history, how it relates to the biology of aging, and the potential for therapeutic interventions via the so-called NAD+ precursors. What is NAD+? Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in all living cells. It is a...
LSN longevity pharmacology
March 02, 2021
This week on Lifespan News, Brent Nally discusses longevity pharmacology, atrophy of the circadian clock, SIRT3 and lung fibrosis, research that suggests that we should look beyond biology to slow aging, and our Science to Save the World episode on ancestral memories. Further Reading Longevity Pharmacology Comes of Age Atrophy of the Neuronal Circadian Clock...
Matt Kaeberlein interview
March 02, 2021
Almost three years ago, Dr. Matt Kaeberlein, a Professor of Pathology and an Adjunct Professor of both Genome Sciences and Oral Health Sciences at the University of Washington in Seattle, outlined the nascent Dog Aging Project (DAP) for our readers in an extensive interview. Along with the intrinsic value of helping our beloved pets live...
X10 Caring about Aging
March 01, 2021
In this episode of X10, we discuss three reasons why people don't care about curing aging. Getting people to care about elderly dying from a deadly disease is relatively easy, but getting them to care about the cause of their frailty and immune susceptibility, aging itself, is a bit different. Sources The elderly are...
Rejuvenation Roundup February
March 01, 2021
As rejuvenation research continues to grow and develop, so do we here at This month's Roundup features quite a few interesting studies along with things that we're doing to make these studies more accessible to the public. LEAF News Take Our Audience Survey!: We'd like to know your opinions and perspective on us and...